Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.58 USD | -2.61% | -1.69% | +18.95% |
05-10 | ANI Pharmaceuticals Seeks M&A | CI |
05-10 | ANI Pharmaceuticals, Inc. Reiterates Earnings Guidance for the Full Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.95% | 1.31B | |
+29.71% | 682B | |
+30.35% | 586B | |
-3.78% | 364B | |
+17.50% | 327B | |
+3.32% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.17% | 165B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Truist Securities Adjusts Price Target on ANI Pharmaceuticals to $72 From $70, Maintains Buy Rating